With an important political event looming ahead, the short-term outlook for the stock market remains hazy, says B Gopkumar, executive vice-president and head of broking at Kotak Securities. In
Drugmaker Dr Reddy’s counts itself among the top three players and claims quality has always been its USP. In an interview with Trushna Udgirkar Nicholas Cappuccino talks about
By Sreenivasa Prasanna, Senior director - corporates, India Ratings & Research
The year 2013 saw an increase in USFDA regulatory actions against Indian pharmaceutical manufacturers. Import alerts which ban import of drugs manufactured at a pharmaceutical facility were issued against
Recently, various notices and import alerts were issued by the United States Food and Drug Administration (USFDA) to Indian pharmaceutical manufacturing units for violation of current Good Manufacturing Practices (CGMP).
Aneesh Srivastava, CIO of IDBI Federal Life Insurance, says the pace of Fed taper, US growth and signals from China will remain key drivers of our market till the elections.
1. How do you balance your family time with your work?
Balance is just another silly measure that adds stress to our lives
Rajesh Laddha, chief financial officer of Piramal Group, says the stock market is looking for a stable political environment, which seems a distant reality till the elections get over.
1. Which was your first insurance policy?When I passed my engineering in 1992 my father asked me to buy the Jeevan Suraksha Policy of LIC
Saibal Ghosh chief investment officer at AEGON Religare Life believes the market will remain slightly under pressure on account of recent tapering effect, muted corporate earnings and election uncertainties.
1. What was your first financial investment?
I subscribed to an IPO and got 50 shares of Sundaram Finance at Rs 10 each